How Fast Does Oxycodone Work and How Long It Lasts

Immediate-release oxycodone typically begins relieving pain within 15 to 30 minutes of swallowing a tablet, with peak effects arriving around the one-hour mark. How long relief lasts depends on the formulation: immediate-release versions wear off in roughly four to six hours, while extended-release tablets are designed to work for about 12 hours. Those numbers are averages, though, and the real-world timeline shifts based on your genetics, kidney function, other medications, and even what you ate beforehand.

Immediate-Release Versus Extended-Release Formulations

The two main oral forms of oxycodone behave quite differently once they hit your stomach. Immediate-release (IR) tablets and liquid solutions release all of the drug at once. Pain relief comes on quickly, but it also fades relatively fast, which is why IR oxycodone is usually dosed four times a day for around-the-clock pain control. Extended-release (ER or CR) tablets use a matrix or coating that slowly dissolves, metering out the drug over many hours. These are taken every 12 hours.

In clinical trials comparing the two, patients with chronic cancer pain and chronic noncancer pain were titrated to stable pain control on either formulation. Among cancer patients, roughly 92% achieved stable relief on the controlled-release version and 79% on the immediate-release version; among noncancer patients, the numbers were 87% and 96%, respectively.¹ The takeaway is that both formulations can achieve effective pain control, but the timeline of onset and duration is fundamentally different. If you are taking IR oxycodone for breakthrough pain on top of an ER regimen, the IR dose kicks in faster and fills the gap while the slower-release tablet keeps working in the background.

What Happens Inside Your Body After a Dose

Oxycodone is absorbed through the lining of your gastrointestinal tract and enters the bloodstream. One reason it works well by mouth is that its oral bioavailability sits above 60%, meaning more than half the dose actually reaches your circulation intact. That is substantially higher than morphine, whose oral bioavailability is only around 20%, leading to more predictable blood levels from person to person with oxycodone.²

Once in the blood, oxycodone crosses into the brain, where it binds primarily to mu-opioid receptors to block pain signals. Research suggests it crosses the blood-brain barrier roughly six times faster than morphine, which may partly explain why many patients report a quick onset of relief.³ The drug is then broken down in the liver, primarily by two enzyme families: CYP3A4, which handles the bulk of metabolism, and CYP2D6, which produces a metabolite called oxymorphone. That metabolite has an affinity for the mu-opioid receptor estimated at 40 to 60 times greater than oxycodone itself.⁴ Only about 10% of the dose leaves the body unchanged through the kidneys; the rest exits as metabolites in the urine, with a small amount via feces.⁵

How Food Changes the Timeline

Whether you take oxycodone on an empty stomach or after a meal can alter how fast it reaches peak levels, though the overall amount absorbed tends to stay about the same. For the immediate-release liquid solution, eating a high-fat meal lowered the peak concentration by about 18% while slightly increasing total absorption to roughly 120% of the fasted value.⁶ In plain terms, food blunts the initial spike but stretches out absorption, so the drug stays in your system a bit longer at slightly lower concentrations. That means the onset of noticeable relief can be delayed if you take an IR dose right after a heavy meal.

Extended-release formulations are less sensitive to food. In one study of an ER oxycodone/acetaminophen combination tablet, a high-fat meal delayed the time to peak concentration by about two hours and pushed back the initial appearance of drug in the blood by roughly 15 minutes, but total drug exposure stayed within the range considered equivalent to fasting.⁷ Another trial of a different ER capsule formulation found no meaningful food effect at all, whether swallowed whole with a meal or sprinkled on applesauce.⁸ The practical point: if you need fast-acting relief from an IR dose, taking it on an empty stomach will get it into your blood sooner. For ER tablets, food makes less of a difference.

Why the Same Dose Hits People Differently

One of the most striking things about oxycodone is how much its effects can vary from person to person, even at identical doses. A big reason is genetic variation in the CYP2D6 enzyme that converts oxycodone to oxymorphone, the far more potent metabolite. People inherit different versions of the CYP2D6 gene, and those versions fall into broad categories: poor metabolizers (who produce very little oxymorphone), normal metabolizers, and ultra-rapid metabolizers (who produce a lot of it).

A large analysis of clinical urine drug tests found a nearly sevenfold difference in the ratio of oxymorphone to oxycodone between ultra-rapid and poor metabolizers. Specimens from poor metabolizers were about five times more likely to have no detectable oxymorphone at all compared to normal metabolizers.⁹ In a controlled experimental pain study, ultra-rapid metabolizers experienced noticeably stronger pharmacological effects from oxycodone, while poor metabolizers showed responses that looked similar to placebo on some pain measures. Blocking CYP2D6 with another drug reduced oxycodone’s pain-relieving effect by about 30%.¹⁰

What this means in practice is that two people given the same oxycodone prescription can have genuinely different experiences. A poor metabolizer may feel it is barely working. An ultra-rapid metabolizer may feel too much effect, including more sedation and a higher risk of side effects. Pharmacogenomic testing can identify which category you fall into, and some pain specialists use those results to guide opioid selection or dosing.

Drug Interactions That Change How Long Oxycodone Stays Active

Because oxycodone depends on CYP3A4 and CYP2D6 to be broken down, any other drug that blocks or ramps up those enzymes can shift how long oxycodone lingers in your body. In a controlled crossover study, healthy volunteers who took both paroxetine (a common antidepressant that inhibits CYP2D6) and itraconazole (an antifungal that inhibits CYP3A4) at the same time saw their oxycodone half-life climb from about 3.8 hours to 6.6 hours, and their overall drug exposure roughly doubled.¹¹ That is a dramatic shift from a single pharmacokinetic interaction.

Some widely used medications are CYP3A4 inhibitors: certain antibiotics (clarithromycin, erythromycin), antifungals (ketoconazole, fluconazole), HIV protease inhibitors, and even grapefruit juice in large quantities. CYP2D6 inhibitors include the antidepressants fluoxetine, paroxetine, and bupropion, as well as some antihistamines. When these are combined with oxycodone, the drug effectively lasts longer and hits harder, raising the risk of excessive sedation or respiratory depression. On the flip side, drugs that induce CYP3A4 (like rifampin or certain anti-seizure medications) can speed up oxycodone metabolism and make it wear off sooner than expected, potentially leaving pain undertreated. If you are prescribed oxycodone alongside any of these medications, your prescriber should adjust timing or dose accordingly.

Kidney Function and Drug Clearance

Even though most oxycodone leaves the body as liver-processed metabolites, those metabolites still need to be excreted through the kidneys. When kidney function is impaired, the metabolites can build up. Patients with chronic kidney disease have been found to have peak plasma concentrations about 50% higher than those with healthy kidneys.⁵ In effect, the drug lasts longer and is more potent in someone with reduced kidney function, which raises the risk of oversedation and breathing problems.

Among opioids used in kidney disease, oxycodone sits in a middle zone: it is considered usable, but with caution and close monitoring. By comparison, morphine and codeine are generally avoided in these patients because their active metabolites accumulate even more dangerously.¹² Older adults are particularly affected because kidney function naturally declines with age, meaning an older person on the same dose as a younger person may effectively be getting a higher drug exposure without anyone changing the prescription.

How Oxycodone Compares to Morphine in Speed and Duration

Oxycodone and morphine are often discussed side by side because they are both first-line opioids for moderate to severe pain. Their speed and duration profiles overlap but are not identical. Oxycodone’s faster crossing of the blood-brain barrier may contribute to a quicker onset of perceived relief for some patients.³ Their lipid solubility is actually similar, but oxycodone’s oral bioavailability is more than three times that of morphine, which means oral oxycodone produces more consistent blood levels from dose to dose and from patient to patient.²

The two drugs also differ in receptor activity. While both primarily work through the mu-opioid receptor, oxycodone has additional activity at kappa-opioid receptors, which may affect how well it works for certain types of visceral or deep-tissue pain. In a randomized trial of cancer patients given intravenous formulations, oxycodone showed a faster onset of analgesia on the second day of treatment compared to morphine.³ None of this means oxycodone is categorically “better.” Both drugs are effective, and the choice between them often comes down to individual tolerance, side-effect profiles, and the type of pain being treated.

How Tolerance Changes the Duration of Relief

With repeated use, the body adapts to opioids through a process called tolerance: the same dose gradually produces less pain relief, less sedation, and less euphoria. At the receptor level, mu-opioid receptors become less responsive over time, a phenomenon known as desensitization.¹³ For someone taking oxycodone regularly over weeks or months, this often shows up as the feeling that pain relief does not last as long as it once did. A dose that used to provide four or five hours of comfort may seem to wear off after three.

Tolerance does not develop evenly across all of oxycodone’s effects. Pain relief and euphoria tend to diminish faster than side effects like constipation, which persists stubbornly even at high doses. This uneven tolerance pattern is one reason long-term opioid therapy becomes increasingly difficult to manage: higher doses chase diminishing pain relief while constipation and other side effects remain or worsen. If you notice that your prescribed dose seems to be wearing off earlier, the right step is a conversation with your prescriber about dose adjustment or alternative strategies, not self-adjusting your timing or dose.

How Long Oxycodone Shows Up on Tests

After the pain-relieving effects have faded, oxycodone and its metabolites remain detectable in the body for some time. Urine drug tests are the most common screening method, and a standard immunoassay designed specifically for oxycodone can detect it and its primary metabolite oxymorphone at concentrations above 100 nanograms per milliliter. In a study of over 1,500 urine specimens from pain management patients, the assay agreed with confirmatory testing in 99.5% of positive cases.¹⁴

As a rough guide, oxycodone is typically detectable in urine for about two to four days after the last dose, though this window stretches with higher doses, longer durations of use, and impaired kidney or liver function. Standard five-panel drug tests used by many employers screen for “opiates” (morphine, codeine) but do not always pick up oxycodone, which is a semi-synthetic opioid. Extended panels that specifically test for oxycodone are needed for reliable detection. Blood tests have a shorter detection window of roughly 24 hours, while hair follicle tests can detect opioid use over a 90-day window, though they are less commonly ordered.

For patients in pain management programs who are supposed to be taking oxycodone, the concern sometimes runs the other direction: a negative test when the patient claims to be compliant. CYP2D6 poor metabolizers, as discussed earlier, may produce so little oxymorphone that the metabolite does not appear on their test at all, which can look like non-adherence even though they are taking the medication as directed.⁹ Awareness of this genetic wrinkle can prevent patients from being unfairly discharged from their pain program over a misleading lab result.